Aridis Pharmaceuticals CFO Fred Kurland resigns effective Aug 4, 2023 due to retirement

Aridis Pharmaceuticals, Inc.

CFO Fred Kurland resigned on August 4, 2023, citing retirement.
Kurland will serve as senior financial consultant to the Company.
VP of Finance Tamara Allen continues to lead all financial accounting and reporting.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Fred Kurland

Chief Financial Officer

Aridis Pharmaceuticals, Inc.

Effective: 2023-08-04
Filed: August 9, 2023, 7:59 PM ET

On August 4, 2023, Fred Kurland resigned as Chief Financial Officer of Aridis Pharmaceuticals, Inc. (the “Company”) due to his retirement.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Fred Kurland resigned as Chief Financial Officer at Aridis Pharmaceuticals, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On August 4, 2023, Fred Kurland resigned as Chief Financial Officer of Aridis Pharmaceuticals, Inc. (the “Company”) due to his retirement.

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-23-027356

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.